• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性健康与泌尿系统疾病的研究优先级

Research prioritization of men's health and urologic diseases.

作者信息

Okland Tyler, Karimkhani Chante, Pederson Hannah, Boyers Lindsay N, Sawyer Mark D, Rove Kyle O, Kenny McCabe C, Steinberg Steven, Naghavi Mohsen, Dellavalle Robert P

机构信息

University of Colorado School of Medicine, Aurora, Colorado, USA.

College of Physicians and Surgeons, Columbia University, New York, NY, USA.

出版信息

Int Braz J Urol. 2017 Mar-Apr;43(2):289-303. doi: 10.1590/S1677-5538.IBJU.2016.0047.

DOI:10.1590/S1677-5538.IBJU.2016.0047
PMID:28128909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5433369/
Abstract

OBJECTIVES

We sought to determine whether disease representation in the Cochrane Database of Systematic Reviews (CDSR) reflects disease burden, measured by the Global Burden of Disease (GBD) Study as disability-adjusted life-years (DALYs).

MATERIALS AND METHODS

Two investigators performed independent assessment of ten men's health and urologic diseases (MHUDs) in CDSR for systematic review and protocol representation, which were compared with percentage of total 2010 DALYs for the ten conditions. Data were analyzed for correlation using Spearman rank analysis.

RESULTS

Nine of ten MHUDs were represented by at least one CDSR review. There was a poor and statistically insignificant positive correlation between CDSR representation and disease burden (rho = 0.42, p = 0.23). CDSR representation was aligned with disease burden for three conditions, greater than disease burden for one condition, and less than disease burden for six conditions.

CONCLUSIONS

These results yield high-quality estimates to inform future research prioritization for MHUDs. While prioritization processes are complex and multi-faceted, disease burden should be strongly considered. Awareness of research priority setting has the potential to minimize research disparities on a global scale.

摘要

目的

我们试图确定Cochrane系统评价数据库(CDSR)中的疾病呈现是否反映了疾病负担,该疾病负担由全球疾病负担(GBD)研究以伤残调整生命年(DALYs)来衡量。

材料与方法

两名研究者对CDSR中十种男性健康和泌尿系统疾病(MHUDs)的系统评价和方案呈现进行了独立评估,并将其与这十种疾病在2010年DALYs总数中的占比进行比较。使用Spearman秩分析对数据进行相关性分析。

结果

十种MHUDs中有九种至少有一篇CDSR综述。CDSR呈现与疾病负担之间存在较弱且无统计学意义的正相关(rho = 0.42,p = 0.23)。CDSR呈现与三种疾病的负担一致,一种疾病的呈现大于其疾病负担,六种疾病的呈现小于其疾病负担。

结论

这些结果产生了高质量的估计,可为未来MHUDs的研究优先级提供参考。虽然优先级确定过程复杂且多方面,但应强烈考虑疾病负担。了解研究优先级设定有可能在全球范围内最大限度地减少研究差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142f/5433369/f8f778b66482/1677-5538-ibju-43-02-0289-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142f/5433369/0f680b479704/1677-5538-ibju-43-02-0289-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142f/5433369/f8f778b66482/1677-5538-ibju-43-02-0289-gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142f/5433369/0f680b479704/1677-5538-ibju-43-02-0289-gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/142f/5433369/f8f778b66482/1677-5538-ibju-43-02-0289-gf02.jpg

相似文献

1
Research prioritization of men's health and urologic diseases.男性健康与泌尿系统疾病的研究优先级
Int Braz J Urol. 2017 Mar-Apr;43(2):289-303. doi: 10.1590/S1677-5538.IBJU.2016.0047.
2
Global burden of eye and vision disease as reflected in the Cochrane Database of Systematic Reviews.全球眼与视力疾病负担在 Cochrane 系统评价数据库中的反映。
JAMA Ophthalmol. 2015 Jan;133(1):25-31. doi: 10.1001/jamaophthalmol.2014.3527.
3
Identifying gaps for research prioritisation: Global burden of external causes of injury as reflected in the Cochrane Database of Systematic Reviews.确定研究重点的差距:Cochrane系统评价数据库中反映的全球外部伤害原因负担
Injury. 2016 May;47(5):1151-7. doi: 10.1016/j.injury.2015.12.019. Epub 2016 Jan 12.
4
Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews.《Cochrane 系统评价数据库中反映的皮肤疾病全球负担》
JAMA Dermatol. 2014 Sep;150(9):945-51. doi: 10.1001/jamadermatol.2014.709.
5
Identifying otolaryngology systematic review research gaps: comparing Global Burden of Disease 2010 results with Cochrane Database of Systematic Review content.确定耳鼻喉科系统评价研究差距:2010 年全球疾病负担研究结果与 Cochrane 系统评价数据库内容比较。
JAMA Otolaryngol Head Neck Surg. 2015 Jan;141(1):67-72. doi: 10.1001/jamaoto.2014.2700.
6
Alignment of systematic reviews published in the Cochrane Database of Systematic Reviews and the Database of Abstracts and Reviews of Effectiveness with global burden-of-disease data: a bibliographic analysis.发表于《考克兰系统评价数据库》和《有效性摘要与评价数据库》的系统评价与全球疾病负担数据的比对:一项文献计量分析
J Epidemiol Community Health. 2015 Jul;69(7):708-14. doi: 10.1136/jech-2014-205389. Epub 2015 Apr 17.
7
Adolescent health: boys matter too.青少年健康:男孩也很重要。
Lancet. 2015 Dec 5;386(10010):2227. doi: 10.1016/S0140-6736(15)01160-5.
8
[Gender-specific aspects in visceral medicine].[内脏医学中的性别特异性方面]
Z Gastroenterol. 2015 Aug;53(8):773. doi: 10.1055/s-0035-1553498. Epub 2015 Aug 18.
9
Male infertility as a window to health.男性不育作为健康之窗。
Fertil Steril. 2018 Oct;110(5):810-814. doi: 10.1016/j.fertnstert.2018.08.015.
10
Identifying gaps in research prioritization: The global burden of neglected tropical diseases as reflected in the Cochrane database of systematic reviews.确定研究优先级中的差距:Cochrane系统评价数据库所反映的被忽视热带病的全球负担。
J Family Med Prim Care. 2015 Oct-Dec;4(4):507-13. doi: 10.4103/2249-4863.174266.

引用本文的文献

1
Quick prioritization of Cochrane reviews on benign conditions of the prostate.快速对关于前列腺良性疾病的Cochrane系统评价进行优先级排序。
Cochrane Evid Synth Methods. 2023 Mar 27;1(2):e12002. doi: 10.1002/cesm.12002. eCollection 2023 Apr.
2
What do we know about evidence-informed priority setting processes to set population-level health-research agendas: an overview of reviews.关于为制定人群层面的健康研究议程而进行的循证优先排序过程,我们了解多少:综述概述
Bull Natl Res Cent. 2022;46(1):6. doi: 10.1186/s42269-021-00687-8. Epub 2022 Jan 6.
3
The Importance of Reporting Clinical and Epidemiological Data in Urology: Local Experiences and Insights from the International Literature.

本文引用的文献

1
Identifying gaps for research prioritisation: Global burden of external causes of injury as reflected in the Cochrane Database of Systematic Reviews.确定研究重点的差距:Cochrane系统评价数据库中反映的全球外部伤害原因负担
Injury. 2016 May;47(5):1151-7. doi: 10.1016/j.injury.2015.12.019. Epub 2016 Jan 12.
2
Alignment of systematic reviews published in the Cochrane Database of Systematic Reviews and the Database of Abstracts and Reviews of Effectiveness with global burden-of-disease data: a bibliographic analysis.发表于《考克兰系统评价数据库》和《有效性摘要与评价数据库》的系统评价与全球疾病负担数据的比对:一项文献计量分析
J Epidemiol Community Health. 2015 Jul;69(7):708-14. doi: 10.1136/jech-2014-205389. Epub 2015 Apr 17.
3
泌尿外科临床和流行病学数据报告的重要性:本地经验及来自国际文献的见解
Medicina (Kaunas). 2020 Oct 30;56(11):581. doi: 10.3390/medicina56110581.
Association between randomised trial evidence and global burden of disease: cross sectional study (Epidemiological Study of Randomized Trials--ESORT).随机试验证据与全球疾病负担的关联:横断面研究(Epidemiological Study of Randomized Trials--ESORT)。
BMJ. 2015 Jan 28;350:h117. doi: 10.1136/bmj.h117.
4
Knowledge, moral claims and the exercise of power in global health.知识、道德主张与全球卫生中的权力行使。
Int J Health Policy Manag. 2014 Nov 8;3(6):297-9. doi: 10.15171/ijhpm.2014.120. eCollection 2014 Nov.
5
Identifying otolaryngology systematic review research gaps: comparing Global Burden of Disease 2010 results with Cochrane Database of Systematic Review content.确定耳鼻喉科系统评价研究差距:2010 年全球疾病负担研究结果与 Cochrane 系统评价数据库内容比较。
JAMA Otolaryngol Head Neck Surg. 2015 Jan;141(1):67-72. doi: 10.1001/jamaoto.2014.2700.
6
Prioritization of systematic reviews leads prioritization of research gaps and needs.
J Clin Epidemiol. 2013 May;66(5):522-3. doi: 10.1016/j.jclinepi.2012.09.007. Epub 2012 Dec 20.
7
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.1990年和2010年20个年龄组中235种死因的全球和区域死亡率:全球疾病负担研究2010的系统分析
Lancet. 2012 Dec 15;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
8
GBD 2010: design, definitions, and metrics.《2010年全球疾病负担研究:设计、定义与衡量指标》
Lancet. 2012 Dec 15;380(9859):2063-6. doi: 10.1016/S0140-6736(12)61899-6.
9
Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting.临床试验应以对相关证据的系统评价为起点和终点:12年了,还在等待。
Lancet. 2010 Jul 3;376(9734):20-1. doi: 10.1016/S0140-6736(10)61045-8.
10
Setting priorities for research: a practical application of 'payback' and expected value of information.确定研究优先级:“回报”与信息期望值的实际应用
Health Econ. 2007 Dec;16(12):1345-57. doi: 10.1002/hec.1225.